MAIA Biotechnology, Inc. (MAIA) has 8 SEC Form 4 insider filings on record in the last 90 days. That includes 5 insider purchases totalling $352K. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 14, 2026 | Vitoc Vlad Chief Executive Officer | +$100,010 | 73,000 | +7% | No | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Guerrero Ramiro Director | +$49,516 | 37,595 | +5% | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 26, 2026 | Guerrero Ramiro Director | +$184,103 | 133,790 | +22% | No | |
|
|
||||||
| Aug. 26, 2026 filed Aug. 24, 2026 | Guerrero Ramiro Director | +$2,386 | 1,794 | +0% | No | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | Guerrero Ramiro Director | +$16,302 | 11,899 | +2% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free